Pure Global

Hemorrhagic Myocardial Infarction Diagnosis by Post-reperfusion Troponin - Trial NCT05872308

Access comprehensive clinical trial information for NCT05872308 through Pure Global AI's free database. This phase not specified trial is sponsored by Rohan Dharmakumar and is currently Recruiting. The study focuses on Acute Myocardial Infarction. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05872308
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT05872308
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Hemorrhagic Myocardial Infarction Diagnosis by Post-reperfusion Troponin
Hemorrhagic Myocardial Infarction Diagnostics With Post-reperfusion Troponin Kinetics

Study Focus

Observational

Sponsor & Location

Rohan Dharmakumar

Indiana University

Indianapolis, United States of America

Timeline & Enrollment

N/A

Jun 01, 2022

Nov 30, 2023

30 participants

Primary Outcome

Diagnostic Threshold

Summary

Pilot trial to determine diagnostic efficacy of post-reperfusion troponin kinetics in
 detection of hemorrhagic myocardial infarction

ICD-10 Classifications

Acute myocardial infarction
Acute myocardial infarction, unspecified
Acute subendocardial myocardial infarction
Certain current complications following acute myocardial infarction
Other current complications following acute myocardial infarction

Data Source

ClinicalTrials.gov

NCT05872308

Non-Device Trial